It is not approved for human consumption, medical, or diagnostic use.
Disclosure of interest: KEVIN ROYCE ANG: NOTHING TO DISCLOSE E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P2003 - ESOC25-95 ASSOCIATION OF CTP PARAMETERS WITH OUTCOMES IN PATIENTS WITH MEDIUM VESSEL OCCLUSION UNDERGOING THROMBECTOMY Yoel Schwartzmann 1 , Hamza Joubran 1 , Tamer Jubeh 1 , Issa Metanis 1 , Aviva Alpernas 2 , Tali Jonas Kimchi 2 , Udi Sadeh 2 , John Moshe Gomori 1 , Jose Cohen 1 , Hen Hallevi 2 , Jeremy Molad 2 , Ronen R Leker 1 1 Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 2 Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Background and Aims: Imaging biomarkers obtained on CT perfusion (CTP) have proven effective in predicting outcomes after EVT in patients with large vessel occlusion stroke
It is crucial to consult a healthcare professional to determine the appropriate dosage and ensure the therapy is suitable for the individual's health condition
Now known as Gerson Therapy, this approach focuses on enabling the body to heal itself by addressing the root causes of degenerative diseases
